| ||
| ||
OncoGenex Pharmaceuticals to Present at Upcoming Investor Conference Sacramento Bee BOTHELL, WA and VANCOUVER, BC, Nov. 9, 2012 -- /PRNewswire/ - OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that Scott Cormack, President and Chief Executive Officer, will provide a corporate presentation at the Lazard Capital ... See all stories on this topic » | ||
| ||
Canadian court clears way for generic Viagra Hamilton Spectator OTTAWA - The Supreme Court of Canada has invalidated the Viagra patent held by pharmaceutical giant Pfizer, opening the marketplace to cheaper versions of the popular erectile dysfunction drug. In a 7-0 decision, the high court sided with Teva Canada's ... See all stories on this topic » | ||
| ||
Orchid Chemicals & Pharmaceuticals sells its stake in China JV for $13.9 million Equity Bulls Orchid had in 2002 entered into a 50:50 JV with North China Pharmaceutical Corporation (NCPC) to set up a Cephalosporing API manufacturing facility located in Shijiazhuang, China. The Orchid Chemicals & Pharmaceuticals Ltd stock closed the day at ... See all stories on this topic » | ||
Cumberland Pharma gets second Acetadote patent notice of allowance from ... pharmabiz.com Cumberland Pharmaceuticals Inc.,a Tennessee-based specialty pharmaceutical company, has received Notice of Allowance from the United States Patent and Trademark Office (USPTO) for a second patent relating to its new formulation of Acetadote ... See all stories on this topic » | ||
SCICLONE PHARMACEUTICALS, INC. : SciClone Reports Financial Results for ... 4-traders FOSTER CITY, CA -- (Marketwire) -- 11/09/12 -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today reported financial results for the third quarter and for the nine months ended September 30, 2012. In the third quarter, ZADAXIN® sales continued to ... See all stories on this topic » | ||
Unilife's Bolus Injector Platform Targeted by Global Pharmaceutical Company ... Sacramento Bee Unilife has been advised that the global pharmaceutical company (the "Customer") is targeting more than five pipeline injectable drugs for use with the Precision-Therapy platform of bolus injectors (wearable, disposable pumps). The first of these ... See all stories on this topic » |
This once a day Google Alert is brought to you by Google.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment